Post-approval studies (Phase 4)Study completedNCT06986369
What this trial is testing
Effects of Rivaroxaban on Vascular FMD in Patients With Stable Atherosclerotic Vascular Diseases
Who this might be right for
Atherosclerosis, Coronary
The University of Hong Kong 140